AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
49 hedge funds and large institutions have $141M invested in AVEO Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding
Funds holding: 49 → 49 (0)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
Holders
49
Holding in Top 10
2
Calls
$1.6M
Puts
$88K
Top Buyers
| 1 | +$18.7M | |
| 2 | +$6.66M | |
| 3 | +$5.98M | |
| 4 |
Millennium Management
New York
|
+$2.82M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.58M |
Top Sellers
| 1 | -$7.1M | |
| 2 | -$2.22M | |
| 3 | -$1.55M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$885K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$872K |